Systemic apomorphine alters HPA axis responses to interleukin-1β adminstration but not sound stress

Psychoneuroendocrinology

Volumn 28, Issue 6, 2003, Pages 715-732

  Buller, K M ^a   Crane, J W ^a   Spencer, S J ^a   Day, T A ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

A2 noradrenergic cells; Apomorphine; Dopamine; Hypothalamic pituitary adrenal axis; Interleukin 1 ; Sound stress

Indexed keywords

APOMORPHINE; CATECHOLAMINE; CORTICOTROPIN; INTERLEUKIN 1BETA; OXYTOCIN; PROTEIN FOS;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CONTROLLED STUDY; FEEDBACK SYSTEM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MALE; MENTAL STRESS; NONHUMAN; NORADRENERGIC NERVE; PENIS ERECTION; PHYSICAL STRESS; PRIORITY JOURNAL; RAT; SOLITARY TRACT NUCLEUS; SOUND; STRESS; THALAMUS MIDLINE NUCLEUS; WHITE NOISE;

EID: 0038516785     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(02)00065-3     Document Type: Article

References (66)

1. Argiolas A., Melis M.R. Neuromodulation of penile erection: An overview of the role of neurotransmitters and neuropeptides. Prog. Neurobiol. 47:1995;235-255.
2. Argiolas A., Melis M.R., Mauri A., Gessa G.L. Paraventricular nucleus lesion prevents yawning and penile erection induced by apomorphine and oxytocin but not by ACTH in rats. Brain Res. 421:1987a;349-352.
3. Argiolas A., Melis M.R., Vargiu L., Gessa G.L. d(CH2)5Tyr(Me)-[Orn8] vasotocin, a potent oxytocin antagonist, antagonizes penile erection and yawning induced by oxytocin and apomorphine, but not by ACTH-(1-24). Eur. J. Pharmacol. 134:(221-224):1987b;1-24.
4. 2c receptor-mediated corticosterone and prolactin but not oxytocin and penile erection responses. Eur. J. Pharmacol. 275:1995;301-305.
5. Baggio G., Ferrari F. Clonidine, DPI, phentolamine and DR-71 antagonism towards (±) N-n-propyl-norapomorphine-produced behavioral effects in rats. Riv. Farmacol. Ter. 8:1980;375-379.
6. Berkenbosch F., Oers J.V., Rey A.D., Tilders F., Besedovsky H. Corticotropin-releasing factor producing neurons in the rat activated by interleukin-1. Science. 238:1987;524-526.
7. Borowsky B., Kuhn C.M. D1 and D2 dopamine receptors stimulate hypothalamo-pituitary-adrenal activity in rats. Neuropharmacology. 31:1992;671-678.
8. Bouthenet M.L., Souil E., Martres M.P., Sokoloff P., Giros B., Schwartz J.C. Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA. Brain Res. 564:1991;203-219.
9. Buijs R.M., Geffard M., Pool C.W., Hoorneman E.M.D. The dopaminergic innervation of the supraoptic and paraventricular nucleus. A light and electron microscopical study. Brain Res. 323:1984;65-72.
10. Buller K.M., Smith D.W., Day T.A. NTS catecholamine cell recruitment by hemorrhage and hypoxia. NeuroReport. 10:1999;3853-3856.
11. Buller K.M., Xu Y., Day T.A. Indomethacin attenuates oxytocin and hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1β J. Neuroendocrinol. 10:1998;519-528.
12. Buller K.M., Xu Y., Dayas C.V., Day T.A. Dorsal and ventral medullary catecholamine cell groups contribute differentially to systemic interleukin-1β-induced HPA axis responses. Neuroendocrinology. 73:2001;129-138.
13. Casolini P., Kabbaj M., Piazza P.V., Angelucci L., Simon H., Le Moal M., Maccari S. The D1 dopamine agonist SKF 38393, but not the D2 agonist LY 171555, decreases the affinity of type II corticosteroid receptors in rat hippocampus and ventral striatum. Neuroscience. 60:1994;939-943.
14. Charles M.A., McGinnis M.Y. Effects of LY163502, a D2 dopaminergic agonist, on the sexual behavior of male rats. Pharmacol. Biochem. Behav. 43:1992;1087-1092.
15. Chen K.-K., Chan J.Y.H., Chang L.S. Dopaminergic neurotransmission at the paraventricular nucleus of hypothalamus in central regulation of penile erection in the rat. J. Urol. 162:(237-242):1999;2.
16. Cheung S., Ballew J.R., Moore K.E., Lookingland K.J. Contribution of dopamine neurons in the medial zona incerta to the innervation of the central nucleus of the amygdala, horizontal diagonal band of Broca and hypothalamic paraventricular nucleus. Brain Res. 808:1998;174-181.
17. Crane J.W., Buller K.M., Day T.A. Involvement of bed nucleus of the stria terminalis in hypothalamic CRF cell responses to a physical but not an emotional stressor. Proc. Aust. Neurosci. Sot. 11:2000;29.
18. Cunningham E.T. Jr., Sawchenko P.E. Anatomical specificity of noradrenergic inputs to the paraventricular and supraoptic nuclei of the rat hypothalamus. J. Comp. Neurol. 274:1988;60-76.
19. Czyrak A., Chocyk A., Makowiak M., Fija K., Wdzony K. Distribution of dopamine D1 receptors in the nucleus paraventricularis of the hypothalamus in rats: an immunohistochemical study. Molec. Brain Res. 85:2000;209-217.
20. Dayas C.V., Buller K.M., Day T.A. Neuroendocrine responses to an emotional stressor: evidence for involvement of the medial but not the central amygdala. Eur. J. Neurosci. 11:1999;2312-2322.
21. Dayas C.V., Buller K.M., Crane J.W., Xu Y., Day T.A. Stressor categorisation: acute physical and psychological stressors elicit distinctive recruitment patterns in the amygdala and in medullary noradrenergic cell groups. Eur. J. Neurosci. 14:2001;1143-1152.
22. Dayas C.V., Xu Y., Buller K.M., Day T.A. Effects of chronic estrogen replacement on stress-induced activation of HPA axis control pathways. J. Neuroendocrinol. 12:2000;784-794.
23. Dragunow M., Faull R. The use of c-fos as a metabolic marker in neuronal pathway tracing. J. Neurosci. Meth. 29:1989;261-265.
24. Drolet G., Adams M., Heaton J. Evidence for the central sites of action of apomorphine-induced erections. Int. J. Imp. Res. 8:1996;108.
25. Eaton M.J., Cheung S., Moore K.E., Lookingland K.J. Dopamine receptor-mediated regulation of corticotropin-releasing hormone neurons in the hypothalamic paraventricular nucleus. Brain Res. 738:1996;60-66.
26. Ericsson A., Kovacs K.J., Sawchenko P.E. A functional anatomical analysis of central pathways subserving the effects of interleukin-1 on stress-related neuroendocrine neurons. J. Neurosci. 14:1994;897-913.
27. Foreman M.M., Hall J.L. Effects of D2-dopaminergic receptor stimulation on male rat sexual behavior. J. Neural. Trans. 68:1987;153-170.
28. Freeman G.B., Thurmond J.B. Monoamines and effects of chlordiazepoxide on the corticosterone response to stress. Physiol. Behav. 37:1986;933-938.
29. Fuller R.W., Snoddy H.D. Elevation of serum corticosterone concentrations in rats by pergolide and other dopamine agonists. Endocrinology. 109:1981;1026-1032.
30. Gancher S.T., Nutt J.G., Woodward W.R. Absorption of apomorphine by various routes in Parkinsonism. Mov. Disord. 6:1991;212-216.
31. Gibbs D.M. Dissociation of oxytocin, vasopressin and corticotropin secretion during different types of stress. Life Sciences. 35:1984;487-491.
32. Goldenberg M.M. Safety and efficacy of sildenafil citrate in the treatment of male erectile dysfunction. Clin. Ther. 20:1998;1033-1048.
33. Heaton J.P. Key issues from the clinical trials of apomorphine SL. World J. Urol. 19:2001;25-31.
34. Heaton J.P.W. Central neuropharmacological agents and mechanisms in erectile dysfunction: the role of dopamine. Neurosci. Biobehav. Rev. 24:2000;561-569.
35. Herman J.P., Cullinan W.E. Neurocircuitry of stress: central control of the hypothalamo-pituitary-adrenocortical axis. Trends Neurosci. 20:1997;78-84.
36. Jezova D., Jurcovicova J., Vigas M., Murgas K., Labrie F. Increase in plasma ACTH after dopaminergic stimulation in rats. Psychopharmacology. 85:1985;201-203.
37. Kloner R.A. Sex and the patient with cardiovascular risk factors: focus on sildenafil. Am. J. Med. 109:(Suppl 9A):2000;13S-21S.
38. Lal S., Tesfaye Y., Thavundayil J.X., Thompson T.R., Kiely M.E., Nair N.P., Grassino A., Dubrovsky B. Apomorphine: clinical studies on erectile impotence and yawning. Prog. Neuropsychopharmacol. Biol. Psych. 13:1989;329-339.
39. Lawrence A.J., Krstew E., Jarrott B. Functional dopamine D2 receptors on rat vagal afferent neurones. Br. J. Pharm. 114:1995;1329-1334.
40. Levesque D., Diaz J., Pilon C., Martres M.-P., Giros B., Souil E., Schott D., Morgat J.-L., Schwartz J.-C., Sokoloff P. Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin. Proc. Natl. Acad. Sci. 89:1992;8155-8159.
41. Li H.Y., Ericsson A., Sawchenko P.E. Distinct mechanisms underlie activation of hypothalamic neurosecretory neurons and their medullary catecholaminergic afferents in categorically different stress paradigms. Proc. Natl. Acad. Sci. 93:1996;2359-2364.
42. Lindvall O., Bjorklund A., Skagerberg G. Selective histochemical demonstration of dopamine terminal systems in rat di- and telencephalon: new evidence for dopaminergic innervation of hypothalamic neurosecretory nuclei. Brain Res. 306:1984;19-30.
43. Liposits Z., Paull W.K. Association of dopaminergic fibers with corticotropin releasing hormone (CRH)-synthesizing neurons in the paraventricular nucleus of the rat hypothalamus. Histochemistry. 93:1989;119-127.
44. Manson A.J., Hanagasi H., Turner K., Patsalos P.N., Carey P., Ratnaraj N., Lees A.J. Intravenous apomorphine therapy in Parkinson's disease clinical and pharmacokinetic observations. Brain. 124:2001;331-340.
45. Melis M.R., Argiolas A., Gessa G.L. Apomorphine-induced penile erection and yawning: site of action in brain. Brain Res. 415:1987;98-104.
46. Melis M.R., Argiolas A., Gessa G.L. Evidence that apomorphine induces penile erection and yawning by releasing oxytocin in the central nervous system. Eur. J. Pharm. 164:1989;565-570.
47. Melis M.R., Argiolas A., Stancampiano R., Gessa G.L. Effect of apomorphine on oxytocin concentrations in different brain areas and plasma of male rats. Eur. J. Pharm. 182:1990;101-107.
48. Melis M.R., Spano M.S., Succu S., Argiolas A. The oxytocin antagonist d(CH2)5Tyr(Me)2-Orn8-vasotocin reduces non-contact penile erections in male rats. Neurosci. Lett. 265:1999;171-174.
49. Morgan J.I., Curran T. Stimulus-transciption coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:1991;421-451.
50. Mulhalll J.P., Bukofzer S., Edmonds A.L., George M. An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction. Clin. Ther. 23:2001;1260-1271.
51. Padma-Nathan H., Auerbach S., Lewis R., Lewand M., Perdok R. The apomorphine study group. Efficacy and safety of apomorphine SL vs. placebo for male erectile dysfunction. J. Urol. 161:1999;S214.
52. Pehek E.A., Thompson J.T., Eaton R.C., Bazzett T.J., Hull E.M. Apomorphine and haloperidol, but not domperidone, affect penile reflexes in rats. Pharmacol. Biochem. Behav. 31:1988;201-208.
53. Plotsky P.M. Pathways to the secretion of adrenocorticotropin: A view from the portal. J. Neuroendocrinol. 3:1991;1-9.
54. Plotsky P.M., Sawchenko P.E. Hypophysial-portal plasma levels, median eminence content and immunohistochemical staining of corticotropin-releasing factor, arginine vasopressin and oxytocin following pharmacological adrenalectomy. Endocrinology. 120:1987;1361-1369.
55. Rivest S., Rivier C. Influence of the paraventricular nucleus of the hypothalamus in the alteration of neuroendocrine functions induced by physical stress or interleukin. Endocrinology. 129:1991;2049-2057.
56. Sachs B.D., Akasofu K., McEldowney S.S. Effects of copulation on apomorphine-induced erection in rats. Pharm. Biochem. Behav. 48:1994;423-428.
57. Sagar S.M., Sharp F.R., Curran T. Expression of c-fos protein in brain: metabolic mapping at the cellular level. Science. 240:1988;1328-1330.
58. Sapolsky R., Rivier C., Yamamoto G., Plotsky P., Vale W.W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science. 238:1987;522-524.
59. Sharif N.A., Nunes J.L., Rosenkrantz R.P., Whiting R.L., Eglen R.M. Quantitative autoradiography demonstrates selective modulation of rat brain regional dopamine (D1 and D2) receptor subtypes after chronic manipulation of dietary salt. Neurochem. Res. 20:1995;121-128.
60. Smith D.W., Buller K.M., Day T.A. Role of ventrolateral medulla catecholamine cells in hypothalamic neuroendocrine cell responses to systemic hypoxia. J. Neurosci. 15:1995;7979-7988.
61. Speakman M.T., Kloner R.A. Viagra and cardiovascular disease. J. Cardiovasc. Pharmacol. Ther. 4:1999;259-267.
62. Stein R.A. Cardiovascular response to sexual activity. Am. J. Cardiol. 86:2000;27F-29F.
63. Uehara A., Gottschall P.E., Dahl R.R., Arimura A. Interleukin-1 stimulates ACTH release by an indirect mechanism which requires endogenous corticotropin releasing factor. Endocrinology. 121:1987;1580-1582.
64. Wagner C.K., Clemens L.G. Neurophysin-containing pathway from the paraventricular nucleus of the hypothalamus to a sexually dimorphic motor nucleus in lumbar spinal cord. J. Comp. Neurol. 336:1993;106-116.
65. Xu Y., Day T.A., Buller K.M. The central amygdala modulates hypothalamic-pituitary-adrenal axis responses to systemic interleukin-1β administration. Neuroscience. 94:1999;175-183.
66. Yokoyama C., Okamura H., Nakajima T., Taguchi J., Ibata Y. Autoradiographic distribution of [3H]YM-09151-2, a high-affinity and selective antagonist ligand for the dopamine D2 receptor group, in the rat brain and spinal cord. J. Comp. Neurol. 344:1994;121-136.